Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing.

Fish oil supplements may not always support brain recovery, as EPA was linked to impaired healing after repeated mild brain ...

Tortugas Neuroscience launched Tuesday with plans to develop drugs licensed from Chinese drugmaker Jiangsu Hansoh and ...

Different psychedelics create very similar brain pattern activity, giving scientists new insight into potential mental health ...

Hundreds of scans hint at how substances such as psilocybin, LSD and ayahuasca alter connections between key areas of the brain.

The need for medical treatments for rare diseases such as Leigh syndrome is high. However, low patient numbers make research ...

Scientists from Johns Hopkins Medicine report new evidence that clusters of brain tissue derived from the cells of patients ...

Seemingly unrelated diseases and conditions like Alzheimer's disease, obesity, chronic pain, traumatic brain injury, and ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

Placebo effects, in which patients experience relief without therapeutic treatment, increasingly have been considered as potentially powerful clinical treatments for ailments such as depression and ...

Alzheimer’s drugs that target the buildup of the amyloid protein on the brain don’t meaningfully help patients, a major ...

A growing body of research suggests astrocytes, star-shaped brain cells once dismissed as support players, may lead the way ...